Next-Generation Sequencing Facilitates Quantitative Analysis of Control and BET bromodomain Inhibitor-treated Uterine Leiomyosarcoma Cell Transcriptome
We report that BET bromodomain inhibition alters multiple biological pathways in uterine leiomyosarcoma cells Overall design: Examine the transcriptome alteration in uterine leiomyosarcoma cells with or without BET bromodomain inhibitors